monovalent bispecific IgG antibodies through novel electrostatic steering mutations at the CH1-CL interface
External Resource: Annotation
| Chain | Chain Class | Chain Subclass | Chain Type | Antigen Name(s) | Provenance Source |
|---|
| B [auth L] | Light Chain | IGKV1 | Kappa | - | SAbDab (2025-10-17) |
| A [auth H] | Heavy Chain | IGHV3 | - | - | SAbDab (2025-10-17) |
| Chain | Name | Target | Provenance Source |
|---|
| B [auth L] | Coprelotamab | ERBB2/CD340/HER2, CD3E, TNFRSF9/CD137/4-1BB, SIRPA | Therapeutic SAbDab (2025-10-17) |
| A [auth H] | Coprelotamab | ERBB2/CD340/HER2, TNFRSF9/CD137/4-1BB, CD3E, SIRPA | Therapeutic SAbDab (2025-10-17) |